Regarding ESCC, although NORAD expression has been reported to be significantly related with a poor post-operative prognosis [43], whether and how NORAD contributes to CDDP resistance remain to be elucidated. The gene discussed is NORAD; the disease is esophageal squamous cell carcinoma.